Australia markets open in 3 hours 42 minutes

ME Jan 2025 4.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.36000.0000 (0.00%)
As of 12:24PM EDT. Market open.
Full screen
Previous close3.3600
Expiry date2025-01-17
Day's range3.3600 - 3.3600
Contract rangeN/A
Open interest44
  • GlobeNewswire

    Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research

    Study aims to build a comprehensive, open-source database of heritable genetics and patient-reported data in lung cancerSUNNYVALE, Calif., July 25, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading genetic health and biopharmaceutical company, in collaboration with 20 lung cancer advocacy organizations, today announced a new study to help advance research in lung cancer. The focus of the Lung Cancer Genetics Study is to better understand the genetics of people with lung cancer

  • GlobeNewswire

    23andMe And Nightingale Health Announce Strategic Collaboration To Pilot Blood Biomarker Panel

    SOUTH SAN FRANCISCO, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading preventive health and therapeutics company, and Nightingale Health Plc, a pioneer in biomarker testing and risk prediction, today announced a strategic collaboration to pilot Nightingale Health’s clinically-validated and cost-effective blood metabolomics panel with a cohort of 23andMe members. Nightingale’s Remote Health Check accurately measures dozens of biomarkers from a single blood sam

  • GlobeNewswire

    23andMe Launches New Genetic Report on Bipolar Disorder

    Provides 23andMe+ Premium members with insight into their likelihood of developing the serious mental health illness based on thousands of genetic variantsSOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, today released a new genetic Bipolar Disorder report (Powered by 23andMe Research) for 23andMe+ Premium members, informing them if they are at higher likelihood for being diagnosed with the co